Entity Details

Primary name CAF17_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ5T440
EntryNameCAF17_HUMAN
FullNamePutative transferase CAF17, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length356
SequenceStatuscomplete
DateCreated2007-02-20
DateModified2021-06-02

Ontological Relatives

GenesIBA57

GO terms

Show/Hide Table
GOName
GO:0003723 RNA binding
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0006783 heme biosynthetic process
GO:0016226 iron-sulfur cluster assembly
GO:0016740 transferase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion

Domains

Show/Hide Table
DomainNameCategoryType
IPR017703 YgfZ/GcvT conserved siteSiteConserved site
IPR027266 GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1FamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615330 OMIMMultiple mitochondrial dysfunctions syndrome 3 (MMDS3)A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. Some patients show failure to thrive, pulmonary hypertension, hypotonia and irritability. Biochemical features include severe combined deficiency of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and reduction in activity of mitochondrial respiratory chain complexes. The disease is caused by variants affecting the gene represented in this entry.
616451 OMIMSpastic paraplegia 74, autosomal recessive (SPG74)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG74 is characterized by a combination of spastic paraplegia, optic atrophy, and peripheral neuropathy with childhood-onset and slow progression into late adulthood. The disease is caused by variants affecting the gene represented in this entry.

Interactions

2 interactions

InteractorPartnerSourcesPublicationsLink
CAF17_HUMANISCA2_HUMANUniProt31831856 details
CAF17_HUMANMIC10_HUMANBioGRID22114354 details